Clinical trial
Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects
NCT03157518 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- June 18, 2018
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.